Bioenergetic and Epigenetic Reprogramming by Obesity in Sepsis

脓毒症中肥胖引起的生物能和表观遗传重编程

基本信息

项目摘要

DESCRIPTION (provided by applicant): Emerging data support that changes in cellular bioenergetics, metabolism and gene expression are integrated during acute and chronic inflammatory diseases. A prominent example of this interaction occurs in obesity, where reduced levels of NAD+ biosensor sirtuin 1 (SirT1) promote chronic inflammation. Obesity substantially increases morbidity and mortality of acute inflammatory sepsis. In contrast with obesity, sepsis increases SirT1 expression, which coordinates a shift from early to adaptive inflammatory responses by modifying chromatin plasticity. The objective of this proposal is to determine how obesity-induced changes in cellular bioenergetics affect systemic microvascular inflammation and multi organ injury associated with sepsis. We hypothesize that obesity worsens sepsis inflammation by dysregulating Sirt1-dependent reprogramming of the inflammatory response. To test this, we have developed sepsis models in normal and obese mice that can track microvascular inflammation in vivo. We will use these models and three aims to evaluate our concept: Aim 1 will test that obesity amplifies early responses and delays or extends adaptation of microvascular and tissue inflammatory responses during sepsis. Aim 2 will test that obesity modifies SirT1-dependent gene expression during the inflammatory response of sepsis. Aim 3 will test that modifying SirT1 or NAD+ alters sepsis inflammatory responses and survival. Completing this study will 1) provide insight into the interplay between chronic and acute inflammatory diseases; and 2) show whether Sirt1 provides a critical NAD+ biosensing axis for integrating metabolic and epigenetic reprogramming during the early and adaptation stages of sepsis.
描述(由申请人提供):新出现的数据支持细胞生物能量学、新陈代谢和基因表达的变化在急性和慢性炎症性疾病期间是整合的。这种相互作用的一个突出例子发生在肥胖症中,NAD+生物传感器sirtuin 1(SirT1)水平的降低促进了慢性炎症。肥胖大大增加了急性炎症性脓毒症的发病率和死亡率。与肥胖相比,脓毒症增加了SirT1的表达,SirT1通过改变染色质的可塑性来协调从早期到适应性炎症反应的转变。这项建议的目的是确定肥胖引起的细胞生物能量学变化如何影响全身微血管炎症和与脓毒症相关的多器官损伤。我们假设肥胖通过失调Sirt1依赖的炎症反应重编程而加重脓毒症炎症。为了测试这一点,我们在正常和肥胖小鼠中建立了脓毒症模型,可以跟踪体内的微血管炎症。我们将使用这些模型和三个目标来评估我们的概念:目标1将测试在脓毒症期间肥胖会放大早期反应,延迟或延长微血管和组织炎症反应的适应。目的2验证在脓毒症炎症反应过程中,肥胖改变SirT1依赖基因的表达。目的3将测试修改SirT1或NAD+改变脓毒症炎症反应和生存。完成这项研究将1)深入了解慢性和急性炎症性疾病之间的相互作用;以及2)表明Sirt1是否提供了一个关键的NAD+生物传感轴,用于在脓毒症的早期和适应阶段整合代谢和表观遗传重新编程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vidula Vachharajani其他文献

Vidula Vachharajani的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vidula Vachharajani', 18)}}的其他基金

Immune Function in Sepsis: Role of Sirtuin
脓毒症中的免疫功能:Sirtuin 的作用
  • 批准号:
    10623046
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
Immuno-metabolic dysfunction in alcohol with sepsis
酒精引起脓毒症的免疫代谢功能障碍
  • 批准号:
    10676302
  • 财政年份:
    2021
  • 资助金额:
    $ 32.67万
  • 项目类别:
Immuno-metabolic dysfunction in alcohol with sepsis
酒精引起脓毒症的免疫代谢功能障碍
  • 批准号:
    10491291
  • 财政年份:
    2021
  • 资助金额:
    $ 32.67万
  • 项目类别:
Immuno-metabolic dysfunction in alcohol with sepsis
酒精引起脓毒症的免疫代谢功能障碍
  • 批准号:
    10296547
  • 财政年份:
    2021
  • 资助金额:
    $ 32.67万
  • 项目类别:
Bioenergetic and Epigenetic Reprogramming by Obesity in Sepsis
脓毒症中肥胖引起的生物能和表观遗传重编程
  • 批准号:
    9040200
  • 财政年份:
    2012
  • 资助金额:
    $ 32.67万
  • 项目类别:
Bioenergetic and Epigenetic Reprogramming by Obesity in Sepsis
脓毒症中肥胖引起的生物能和表观遗传重编程
  • 批准号:
    8500394
  • 财政年份:
    2012
  • 资助金额:
    $ 32.67万
  • 项目类别:
Bioenergetic and Epigenetic Reprogramming by Obesity in Sepsis
脓毒症中肥胖引起的生物能和表观遗传重编程
  • 批准号:
    8828236
  • 财政年份:
    2012
  • 资助金额:
    $ 32.67万
  • 项目类别:
Bioenergetic and Epigenetic Reprogramming by Obesity in Sepsis
脓毒症中肥胖引起的生物能和表观遗传重编程
  • 批准号:
    8371395
  • 财政年份:
    2012
  • 资助金额:
    $ 32.67万
  • 项目类别:
Pathological Interaction of Obesity and Sepsis: Role of Adipokines
肥胖和脓毒症的病理相互作用:脂肪因子的作用
  • 批准号:
    7902089
  • 财政年份:
    2009
  • 资助金额:
    $ 32.67万
  • 项目类别:
Pathological Interaction of Obesity and Sepsis: Role of Adipokines
肥胖和脓毒症的病理相互作用:脂肪因子的作用
  • 批准号:
    7736979
  • 财政年份:
    2009
  • 资助金额:
    $ 32.67万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 32.67万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了